IRWD profile · all as-reported value updates

IRONWOOD PHARMACEUTICALS INC (IRWD) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

Metric	FY	Earliest XBRL-filed value	Currently on file	Difference	Difference %	Label	Filing links	Notes
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2018	8,621,000 filed 2019-02-25 · 10-K	351,000 filed 2021-02-17 · 10-K	-8,270,000	-95.93%	revised comparative figure	0001558370-19-001005 0001558370-21-001136	3 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2017	-77,385,000 filed 2018-02-22 · 10-K	-15,363,000 filed 2020-02-13 · 10-K	62,022,000	+80.15%	revised comparative figure	0001558370-18-000927 0001558370-20-000779	3 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2018	-238,892,000 filed 2019-02-25 · 10-K	-150,670,000 filed 2021-02-17 · 10-K	88,222,000	+36.93%	revised comparative figure	0001558370-19-001005 0001558370-21-001136	3 filed observations examined for this concept and period.
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2017	4,211,000 filed 2018-02-22 · 10-K	2,803,000 filed 2020-02-13 · 10-K	-1,408,000	-33.44%	revised comparative figure	0001558370-18-000927 0001558370-20-000779	3 filed observations examined for this concept and period.
Operating cash flow NetCashProvidedByUsedInOperatingActivities	2017	-99,563,000 filed 2018-02-22 · 10-K	-100,753,000 filed 2020-02-13 · 10-K	-1,190,000	-1.18%	revised comparative figure	0001558370-18-000927 0001558370-20-000779	3 filed observations examined for this concept and period.